Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Chicken eggs used to grow patient cancer cells in new automated system

NCT ID NCT05472532

Knowledge-focused Sponsor: Hospices Civils de Lyon Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested whether an automated system can grow cancer cells from patient samples (blood, fluid, or tumor tissue) inside chicken eggs. Researchers aimed to see if at least half of the samples would successfully grow. The goal is to create a better, cheaper way to study cancer and test drugs without using expensive mouse models.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If successful, this method could provide a faster, cheaper way to grow patient cancer cells for research, potentially speeding up drug testing.
What could go wrong
This is an early-stage feasibility study, not a treatment trial. The method may not work for all cancer types or may not translate to better patient outcomes.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

101 people

The number who actually took part.

Started

Feb 2023

Finished

Feb 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

* Inclusion Criteria for all cohorts \* : * Age \> 18 * Signed consent * Inclusion criteria for the "Prostate" cohort: * prostate adenocarcinoma histologically proven * metastatic situation * at least 2 metastatic sites * Evolutionary disease that requires a new treatment * Inclusion criteria for the "Breast" cohort: * HER2+ or RH+ breast adenocarcinoma histologically proven * metastatic situation * at least 2 metastatic sites * Evolutionary disease that requires a new treatment * Inclusion criteria for the "Lung" cohort: * Non Small Lung cancer histologically proven * metastatic situation * at least 2 metastatic sites * Evolutionary disease that requires a new treatment * Inclusion criteria for "Ovarian" cohort: * Ovarian cancer histologically proven * Presence of peritoneal carcinomatosis (stage IIIC or IV); with or without presence of peritoneal fluid * Inclusion criteria for "Colo-Rectal" cohort: * Colo-rectal cancer histologically proven * Presence of peritoneal carcinomatosis, with or without presence of peritoneal fluid * Evolutionary disease that requires a new treatment * Inclusion criteria for "Gastric" cohort: * Gastric cancer histologically proven * Presence of peritoneal carcinomatosis, with or without presence of peritoneal fluid * Exclusion Criteria for all cohorts \* : * Weight \<50kg * Parallel participation in a doubled blinded study * Brain or ganglionary metastasis only

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Breast cancer are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

breast cancer breast neoplasm gastric cancer gastric neoplasm HER2 positive breast carcinoma hormone receptor-positive breast cancer lung cancer lung neoplasm metastatic malignant neoplasm metastatic prostate carcinoma neoplasm Neoplasm Metastasis non-small cell lung carcinoma ovarian cancer peritoneal carcinomatosis prostate cancer

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Breast cancer Cancer metastatic Gastric cancer Lung cancer Ovarian cancer Prostate cancer

Contacts and locations

Locations

  • Centre Hospitalier Lyon Sud

    Pierre-Bénite, 69495, France

  • Centre Hospitalier Lyon Sud - Department of Medical Oncology

    Pierre-Bénite, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.